Kitai, H., & Ebi, H. (2016). Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer. Small GTPases.
Style de citation ChicagoKitai, Hidenori, et Hiromichi Ebi. "Key Roles of EMT for Adaptive Resistance to MEK Inhibitor in KRAS Mutant Lung Cancer." Small GTPases 2016.
Style de citation MLAKitai, Hidenori, et Hiromichi Ebi. "Key Roles of EMT for Adaptive Resistance to MEK Inhibitor in KRAS Mutant Lung Cancer." Small GTPases 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.